Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas eKlingebiel"'
Autor:
Eva eRettinger, Andreas eGlatthaar, Behnaz eAhangarian Abhari, Sarah eOelsner, Verena ePfirrmann, Sabine eHuenecke, Selim eKuci, Hermann eKreyenberg, Andre M Willasch, Thomas eKlingebiel, Simone eFulda, Peter eBader
Publikováno v:
Frontiers in Pediatrics, Vol 2 (2014)
Allogeneic hematopoietic stem cell transplantation (HSCT) is an established treatment option for high-risk hematological malignancies, and may also be offered to patients with solid malignancies refractory to conventional therapies. In case of patien
Externí odkaz:
https://doaj.org/article/c6fb2d43c2db49cd9c064990b604417b
Autor:
Ulrike eKoehl, Claudia eBrehm, Sabine eHuenecke, Stephan eKloess, Melanie eBremm, Stefanie Yvonne eZimmermann, Evelyn eUllrich, Jan eSoerensen, Andrea eQuaiser, Stephanie eErben, Claudia eWunram, Tanja eGardlowski, Eileen eAuth, Torsten eTonn, Chritian eSeidl, Sandrine eMeyer-Monard, Martin eStern, Jakob ePassweg, Thomas eKlingebiel, Peter eBader, Dirk eSchwabe, Ruth eEsser
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
Allogeneic Natural Killer (NK) cells are used for adoptive immunotherapy after stem cell transplantation. In order to overcome technical limitations in NK cell purification and activation, the following study investigates the impact of different vari
Externí odkaz:
https://doaj.org/article/34924019ead54cbf941989df57fcfc55
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipi
Externí odkaz:
https://doaj.org/article/b080c5bbe7de48b299c63dbe6d064a38
Autor:
Eva eRettinger, Vida eMeyer, Hermann eKreyenberg, Andreas eVolk, Selim eKuci, Andre eWillasch, Ewa eKoscielniak, Simone eFulda, Winfried eWels, Halvard eBoenig, Thomas eKlingebiel, Peter eBader
Publikováno v:
Frontiers in Oncology, Vol 2 (2012)
Allogeneic stem cell transplantation (allo-SCT) has become an important treatment modality for patients with high risk acute myeloid leukemia (AML) and is also under investigation for soft tissue sarcomas. The therapeutic success is still limited by
Externí odkaz:
https://doaj.org/article/3b376ad7b03e42619e49cb025ef81677